Single-Dose Psilocybin Treatment for Major Depressive Disorder

Oregon launches legal psilocybin access amid high demand and hopes

"…found no detectable difference in altered states of consciousness induced by 20 mg psilocybin, 100 µg LSD, or 500 mg mescaline”, and no severe side effects were noted for any substance"

Review suggested that "psilocybin may be an effective form of treatment for cancer-related psychiatric distress, treatment-resistant depression and addiction" and that "there are some reports of psilocybin being useful when treating obsessive-compulsive disorder and cluster headaches."

Psilocybin Decelerates Cellular Senescence

A trial finds that a dose of the psychedelic psilocybin administered with psychological support is a safe and acceptable treatment for patients with anorexia nervosa and may decrease eating-disorder behaviours in some patients.

Psilocybin’s effects on cognition and creativity: A scoping review | Journal of Psychopharmacology [Jul 2023]

Australia to prescribe MDMA and psilocybin for PTSD and depression

A new study indicates that reductions in experiential avoidance play a significant role in the therapeutic effects of psilocybin-assisted therapy among depressed patients, leading to improvements in well-being and reductions in depression severity…

Spontaneous and deliberate creative cognition during and after psilocybin (2021)